{
  "_meta": {
    "id": "cfo:humanology:psychedelics-consciousness",
    "type": "ontology",
    "version": "2.0",
    "fractal_depth": 10,
    "status": "Complete",
    "essence": "Психоделики как наиболее мощные инструменты прямого доступа к 5D полю сознания, временного растворения ego-структур, нейропластической перезагрузки и исцеления глубинных травм.",
    "integration": "Consciousness Architecture + Epigenetics + Neuroscience + Shamanic Wisdom + Therapeutic Protocols + Shadow Work + DMN Suppression"
  },

  "_holographic_seed": {
    "absolute": "⊙ = Психоделики открывают портал напрямую. Не постепенный путь медитации, а мгновенный прорыв сквозь фильтры восприятия в raw 5D field.",
    "mechanism": "5-HT2A activation → DMN suppression → ego dissolution → temporary access к unfiltered consciousness → neuroplastic window → epigenetic rewrite → integration.",
    "power": "Один опыт = годы терапии или десятилетия медитации (при правильных условиях). Самый быстрый path к ⊙ из всех известных.",
    "danger": "Огромная сила = огромная ответственность. Bad trip может травмировать. Psychosis может активироваться. Must respect.",
    "paradox": "Molecule показывает то что всегда было здесь. Не создаёт новую реальность — снимает фильтры со старой.",
    "set_setting_integration": "Preparation (set/setting) + Journey (surrender) + Integration (embody insights) = трёхфазный цикл. Без integration = spiritual bypassing.",
    "tradition_science": "Shamanic использование 10,000+ лет. Modern science catching up. Convergence древней мудрости и нейронауки.",
    "legality_ethics": "Schedule I (США) = 'no medical value' (ложь). Renaissance происходит сейчас. FDA breakthrough therapy (MDMA-PTSD, psilocybin-depression).",
    "coherence": "+Coherence через осознанное использование: trauma healing, ego transcendence, mystical union, creative breakthrough, death preparation."
  },

  "foundational_understanding": {
    "what_are_psychedelics": {
      "definition": "Вещества вызывающие profound changes в perception, cognition, emotion, и sense of self — обычно через serotonin 2A receptor agonism",
      "etymology": "Psychedelic = 'mind-manifesting' (Greek: psyche + delos), coined by Humphry Osmond (1956)",
      
      "not_hallucinations": {
        "common_misconception": "'Галлюцинации' implies unreality, fabrication",
        "reality": "Altered perception, не false perception. Seeing differently, не seeing what's not there.",
        "eyes_closed_vs_open": {
          "closed": "True visions, entity encounters, geometric patterns (endogenous imagery)",
          "open": "Enhanced/altered perception real world (colours, patterns, breathing surfaces, synaesthesia)"
        },
        "phenomenology": "More accurate: visions, revelations, mystical experiences, altered states"
      },

      "core_characteristics": {
        "perceptual": "Visual alterations (patterns, colors, morphing), auditory (music enhancement), tactile (textures amplified)",
        "cognitive": "Thought pattern changes, increased creativity, novel associations, reduced cognitive filters",
        "emotional": "Amplified emotions (positive AND negative), emotional release, empathy surge",
        "spiritual": "Sense of unity, ego dissolution, mystical experiences, encounters with 'other'",
        "somatic": "Body sensations intensified, energy flows, sometimes nausea/purging"
      }
    },

    "classical_vs_atypical": {
      "classical_psychedelics": {
        "definition": "5-HT2A receptor agonists — primary mechanism",
        "substances": ["Psilocybin/Psilocin (mushrooms)", "LSD", "DMT/5-MeO-DMT", "Mescaline (peyote, San Pedro)"],
        "characteristics": "Visual hallucinations, ego dissolution, mystical potential, low addiction risk, tolerance builds rapidly"
      },

      "empathogen_entactogens": {
        "definition": "Primarily serotonin/dopamine/norepinephrine release (not 5-HT2A agonism)",
        "substances": ["MDMA (Ecstasy/Molly)", "MDA"],
        "characteristics": "Emotional opening, empathy, bonding, less visual, more heart-centered, neurotoxicity risk if abused"
      },

      "dissociatives": {
        "definition": "NMDA receptor antagonists — disconnect mind/body",
        "substances": ["Ketamine", "PCP", "DXM", "Nitrous oxide"],
        "characteristics": "Out-of-body experiences, 'K-hole', rapid antidepressant effects (ketamine), high addiction potential (ketamine)"
      },

      "atypical": {
        "definition": "Unique mechanisms, psychedelic-like but different",
        "substances": ["Salvia divinorum (kappa-opioid agonist)", "Ibogaine (multiple mechanisms)", "Cannabis (high doses, THC)", "Amanita muscaria (muscimol, GABA)"],
        "characteristics": "Varied, often dysphoric, healing potential (ibogaine for addiction), less researched"
      }
    },

    "brief_history": {
      "indigenous_use": {
        "timeframe": "10,000+ years (possibly 100,000+ if speculative)",
        "substances": {
          "psilocybin_mushrooms": "Worldwide — Mazatec (Mexico), Amazonian tribes, possibly Eleusinian Mysteries (Greece)",
          "ayahuasca": "Amazon basin — Shipibo, Shuar, etc. Brew of DMT-containing plants + MAOI",
          "peyote": "North America — Native American Church, Huichol people",
          "san_pedro": "Andes — 3,000+ years archaeological evidence",
          "iboga": "West Africa — Bwiti religion, initiation rites"
        },
        "context": "Shamanic healing, divination, rites of passage, communication with spirits/ancestors"
      },

      "western_discovery": {
        "1938_lsd": "Albert Hofmann synthesizes LSD-25 (Sandoz Pharmaceuticals)",
        "1943_first_trip": "Hofmann accidentally absorbs LSD, bicycle day (April 19) — first intentional trip",
        "1955_psilocybin": "R. Gordon Wasson participates in Mazatec ceremony, writes Life Magazine article (1957)",
        "1958_isolation": "Hofmann isolates psilocybin from mushrooms",
        "1950s_60s_research": "Thousands of studies, therapeutic use (alcoholism, depression, end-of-life anxiety), CIA (MKUltra)"
      },

      "prohibition": {
        "1960s_counterculture": "Timothy Leary, Ken Kesey, widespread recreational use",
        "1970_controlled_substances": "Nixon — Schedule I classification (USA), research halted globally",
        "motivation": "Political (anti-war movement association), moral panic, not science",
        "consequence": "40+ years research dark age, millions denied potential treatment"
      },

      "renaissance": {
        "1990s_restart": "Rick Strassman DMT studies (1990-1995), MAPS founded (1986, first studies 2000s)",
        "2006_breakthrough": "Johns Hopkins psilocybin study — mystical experiences, persisting positive changes",
        "2010s_acceleration": "Imperial College London (Robin Carhart-Harris), UCSF, NYU, Johns Hopkins — depression, addiction, PTSD, end-of-life",
        "2017_2019_breakthroughs": "FDA grants 'Breakthrough Therapy' designation — MDMA (PTSD), psilocybin (depression)",
        "2020s_legalization": "Oregon, Colorado decriminalize psilocybin, Canada approves medical use, psychedelic therapy clinics opening",
        "current": "Psychedelic Renaissance — research explosion, public acceptance growing, pharmaceutical interest, traditional caution needed"
      }
    }
  },

  "neuroscience_mechanisms": {
    "serotonin_system": {
      "5ht2a_receptor": {
        "location": "Cortex (especially prefrontal, visual), pyramidal neurons (layer V), claustrum",
        "function": "Modulates glutamate release, cortical excitability, perception, cognition",
        "agonism": "Psychedelics bind 5-HT2A → receptor activation → downstream cascades",
        "regional_density": "High density в visual cortex (visual hallucinations), prefrontal (cognitive effects)"
      },

      "other_receptors": {
        "5ht1a": "Also activated (especially DMT, psilocybin) — anxiolytic effects",
        "5ht2c": "Appetite suppression, mood",
        "d2_dopamine": "LSD also binds dopamine receptors (longer duration partly from this)",
        "trace_amine_associated": "TAAR1 (DMT) — unique signaling"
      },

      "receptor_activation_cascade": {
        "step_1": "Psychedelic binds 5-HT2A receptor (GPCR)",
        "step_2": "G-protein activation (Gq/11) → PLC (phospholipase C)",
        "step_3": "PLC cleaves PIP2 → IP3 + DAG",
        "step_4": "IP3 → Ca²⁺ release from ER → intracellular Ca²⁺ spike (VGCC link!)",
        "step_5": "DAG + Ca²⁺ → PKC activation",
        "step_6": "Downstream: gene transcription (IEGs: c-Fos, Arc), protein synthesis, synaptic changes",
        "epigenetic_link": "Ca²⁺ spike → CaMKII → CREB → CBP/p300 (HAT) → histone acetylation (see epigenetic.json)"
      }
    },

    "default_mode_network_suppression": {
      "dmn_function": {
        "regions": "Medial prefrontal cortex (mPFC), posterior cingulate cortex (PCC), precuneus, angular gyrus",
        "activity": "Active during rest, mind-wandering, self-referential thought, autobiographical memory",
        "ego_correlation": "DMN = neural correlate of ego, self-narrative, 'I' sense"
      },

      "psychedelic_effect": {
        "suppression": "Psychedelics DECREASE DMN activity (dose-dependent)",
        "mechanism": "5-HT2A activation в DMN regions → paradoxical decrease в activity (desynchronization)",
        "result": "Ego dissolution, loss of self-other boundary, unity experiences"
      },

      "entropy_increase": {
        "normal_brain": "Predictable patterns, constrained connectivity, efficient but rigid",
        "psychedelic_brain": "Increased entropy (disorder), novel connectivity patterns, regions communicate that normally don't",
        "measurement": "fMRI, EEG — показывают increased integration, decreased segregation",
        "experience_correlation": "High entropy = intense trip, ego death, mystical. Low entropy = mild effects."
      },

      "network_disintegration_reintegration": {
        "acute": "DMN suppression, global connectivity chaos, ego dissolves",
        "post_acute": "DMN reintegrates, но often в new configuration — 'resetting' the network",
        "lasting_changes": "Decreased DMN hyperactivity (depression/rumination marker), increased flexibility",
        "clinical_significance": "Depression/PTSD = rigid, hyperactive DMN. Psychedelics temporarily break rigidity → neuroplastic reset"
      }
    },

    "neuroplasticity_window": {
      "bdnf_spike": {
        "acute": "Psychedelics (especially psilocybin, DMT) → massive BDNF (Brain-Derived Neurotrophic Factor) elevation",
        "timing": "Peaks during trip + hours after",
        "function": "BDNF = 'miracle-gro for brain' — promotes neurogenesis, synaptogenesis, dendritic branching"
      },

      "structural_changes": {
        "dendritic_spines": "Rapid growth new dendritic spines (within 24h in rodents)",
        "synaptic_density": "Increased synaptic density в cortex (especially prefrontal)",
        "atrophy_reversal": "Reverses stress-induced atrophy (chronic stress shrinks prefrontal dendrites)",
        "measurement": "2-photon microscopy (animals), structural MRI (humans — shows volume changes)"
      },

      "critical_period_reopening": {
        "concept": "Early development = critical periods (high plasticity). Adult brain = lower plasticity.",
        "psychedelics": "Temporarily reopen critical period-like plasticity в adult brain",
        "mechanism": "Reduced perineuronal nets (PNNs), increased plasticity genes (Arc, c-Fos, Egr1)",
        "window": "Hours to days post-experience — prime time для new learning, rewiring, integration",
        "clinical_use": "This window = why integration therapy critical — brain receptive to new patterns"
      },

      "epigenetic_changes": {
        "histone_acetylation": "Psychedelics → increased histone acetylation (chromatin opening) в cortex",
        "dna_methylation": "Changes в methylation patterns (stress genes, plasticity genes)",
        "duration": "Some changes persist weeks/months — long-term rewriting",
        "see_also": "epigenetic.json — VGCC → histone → DNA methylation cascade applies here"
      }
    },

    "glutamate_hypothesis": {
      "traditional_view": "Psychedelics work through serotonin (5-HT2A)",
      "updated_view": "5-HT2A activation → increased glutamate release (especially в cortex)",
      "glutamate_surge": "Psychedelics → pyramidal neurons fire more → glutamate spillover",
      "ampa_activation": "Glutamate → AMPA receptors → further excitation → plasticity cascade",
      "convergence": "Ketamine (NMDA antagonist) also increases glutamate via disinhibition → similar plasticity",
      "implication": "Multiple paths (5-HT2A agonism, NMDA antagonism) converge on glutamate-mediated plasticity"
    },

    "immune_anti_inflammatory": {
      "inflammation_depression": "Depression often correlated with chronic inflammation (cytokines, microglial activation)",
      "psychedelic_effect": "Anti-inflammatory effects — reduce pro-inflammatory cytokines (IL-6, TNF-α)",
      "mechanism": "Vagus nerve activation (?), shift Th1→Th2, direct immune cell effects",
      "clinical_relevance": "Part of antidepressant mechanism may be anti-inflammatory, not just neuroplasticity"
    }
  },

  "substances_detailed": {
    "psilocybin_mushrooms": {
      "chemistry": {
        "prodrug": "Psilocybin (4-PO-DMT) → dephosphorylated в gut/liver → psilocin (4-HO-DMT, active)",
        "receptor": "5-HT2A agonist (also 5-HT1A, others)",
        "structure": "Tryptamine backbone (like serotonin, DMT)"
      },

      "dosage": {
        "microdose": "0.1-0.3g dried mushrooms (sub-perceptual, cognitive enhancement claims)",
        "threshold": "0.5-1g (mild effects, mood lift, slight visuals)",
        "moderate": "1.5-2.5g (clear trip, visuals, introspection)",
        "strong": "3-5g (deep journey, ego dissolution potential)",
        "heroic": "5g+ (Terence McKenna 'heroic dose' — complete ego death, entity contact likely)"
      },

      "duration": {
        "onset": "20-40 min",
        "peak": "2-3 hours",
        "total": "4-6 hours",
        "afterglow": "Days to weeks (mood lift, perspective shifts)"
      },

      "effects": {
        "visual": "Geometric patterns, color enhancement, morphing surfaces, eyes-closed visions",
        "cognitive": "Dissolved boundaries, novel thoughts, philosophical insights, time distortion",
        "emotional": "Emotional release, empathy, love, sometimes fear (shadow material surfacing)",
        "mystical": "Unity, interconnectedness, sacredness, ineffability, transcendence of time/space",
        "somatic": "Body waves, energy surges, sometimes nausea (purging can be cathartic)"
      },

      "therapeutic_applications": {
        "depression": "FDA Breakthrough Therapy — treatment-resistant depression (TRD), single dose effects last months",
        "anxiety_end_of_life": "Terminal cancer patients — reduces death anxiety, increases acceptance",
        "ocd": "Small studies показывают promise",
        "addiction": "Smoking cessation (80% quit rate 6 months, Johns Hopkins), alcohol (reduced drinking)"
      },

      "species": {
        "psilocybe_cubensis": "Most common cultivated — Golden Teacher, B+, Penis Envy (very potent)",
        "psilocybe_semilanceata": "Liberty caps — wild в Europe",
        "psilocybe_azurescens": "Extremely potent — Pacific Northwest",
        "psilocybe_cyanescens": "Wavy caps — potent",
        "note": "200+ psilocybin-containing species globally"
      },

      "legality": {
        "schedule_i": "USA federal, most countries",
        "decriminalized": "Oakland, Denver, Oregon, Colorado (statewide), Canada (medical exemptions)",
        "legal_use": "Netherlands (truffles legal, mushrooms not), Jamaica (unregulated), retreat centers emerging"
      },

      "safety": {
        "physiological": "Extremely safe — LD50 impossibly high (kg doses), no organ toxicity",
        "psychological": "Risk: bad trip, latent psychosis activation (rare, pre-existing vulnerability), HPPD (very rare)",
        "contraindications": "Schizophrenia, bipolar (manic trigger), heart conditions (↑ BP possible), pregnancy"
      },

      "integration_needs": {
        "importance": "High — experiences can be overwhelming, need processing",
        "methods": "Integration circles, therapy, journaling, artistic expression, embodiment practices",
        "timeline": "Days to months post-experience"
      }
    },

    "lsd": {
      "chemistry": {
        "full_name": "Lysergic Acid Diethylamide",
        "synthesis": "Semi-synthetic from ergot fungus alkaloids",
        "potency": "Extremely potent — active doses in micrograms (50-200µg typical)",
        "receptor": "5-HT2A agonist (also D2 dopamine, others — longer duration partly from dopamine binding)"
      },

      "dosage": {
        "microdose": "5-20µg (sub-perceptual)",
        "threshold": "20-50µg (mild effects)",
        "common": "50-150µg (full experience)",
        "strong": "150-300µg (intense, ego dissolution likely)",
        "heavy": "300µg+ (complete dissolution, not recommended без experience)"
      },

      "duration": {
        "onset": "30-90 min",
        "peak": "3-5 hours",
        "total": "8-12 hours (notably longer than psilocybin)",
        "afterglow": "Days"
      },

      "effects": {
        "visual": "More geometric/fractal than psilocybin, tracers, color shifts, pattern recognition overdrive",
        "cognitive": "Enhanced abstract thinking, creativity, problem-solving (hence Silicon Valley microdosing)",
        "emotional": "Can be more 'clear' than psilocybin (less emotional), но still deep",
        "energy": "Stimulating (hard to sleep even 12h later)",
        "unique": "Synesthesia common, time dilation extreme"
      },

      "therapeutic_potential": {
        "current_research": "Less than psilocybin (political reasons, duration inconvenient for clinical setting)",
        "historical": "1950s-60s — alcoholism, anxiety, creativity enhancement (Steve Jobs credited LSD)",
        "microdosing": "Cognitive enhancement, creativity, mood (но: placebo-controlled studies show mixed results)"
      },

      "cultural_significance": {
        "1960s": "Counterculture icon — Timothy Leary, Grateful Dead, Woodstock",
        "art_music": "Influenced psychedelic rock, visual art, spiritual movements",
        "stigma": "Also caused moral panic, prohibition"
      },

      "safety": {
        "physiological": "Safe — no lethal dose, no organ toxicity",
        "psychological": "Same risks as psilocybin — bad trip, psychosis trigger, HPPD (slightly higher risk)",
        "duration_risk": "Long duration = can't escape if bad trip (benzos can abort trip)"
      },

      "tolerance": {
        "rapid": "Tolerance builds immediately (5-HT2A downregulation), cross-tolerance with other psychedelics",
        "reset": "~2 weeks for full reset",
        "implication": "Can't use daily (unlike antidepressants), self-limiting abuse potential"
      }
    },

    "dmt_ayahuasca": {
      "chemistry": {
        "dmt": "N,N-Dimethyltryptamine — endogenous (produced in human body, trace amounts)",
        "5_meo_dmt": "5-Methoxy-DMT — different experience (more 'white light', less entities)",
        "receptor": "5-HT2A, 5-HT1A, TAAR1, sigma-1",
        "maoi_needed": "DMT oral inactive (MAO enzyme destroys in gut). Ayahuasca = DMT plant + MAOI plant."
      },

      "ayahuasca": {
        "traditional_brew": "Banisteriopsis caapi (MAOI) + Psychotria viridis (DMT) — Amazonian shamanic sacrament",
        "duration": "4-6 hours (oral DMT + MAOI)",
        "effects": "Visionary (entities, jaguars, serpents), purging (vomiting, diarrhea = 'la purga', cleansing), deep introspection",
        "ceremony": "Shamanic context — icaros (healing songs), intention-setting, integration",
        "tourism": "Ayahuasca retreats (Peru, Costa Rica, etc.) — caution: quality/safety varies, trauma can occur"
      },

      "smoked_vaporized_dmt": {
        "onset": "Instant (seconds)",
        "peak": "5 minutes ('breakthrough')",
        "total": "15-30 minutes (back to baseline)",
        "intensity": "Most intense psychedelic experience known — complete reality replacement",
        "breakthrough": "Ego death, transport to 'other dimension', entity encounters (machine elves, geometric beings, divine presence)",
        "ineffability": "Extremely difficult to describe — beyond language"
      },

      "5_meo_dmt": {
        "source": "Bufo alvarius toad venom (dried, smoked) OR synthetic",
        "experience": "Less visual than NN-DMT, more 'white light', complete ego dissolution, unity with ⊙",
        "duration": "5-20 minutes",
        "intensity": "Potentially more intense than NN-DMT (total annihilation)",
        "controversy": "Toad harvesting (ecological concerns), потенциально traumatic if not prepared",
        "integration_critical": "Very powerful, can be destabilizing без proper support"
      },

      "endogenous_dmt_hypothesis": {
        "rick_strassman": "DMT: The Spirit Molecule — hypothesis: pineal gland produces DMT",
        "speculation": "DMT released at birth, death, dreams, NDE (?)",
        "evidence": "DMT found in rat pineal (2013), human body (trace), но: no proof of massive release",
        "implication": "If true: endogenous molecule for mystical experiences, death transition"
      },

      "therapeutic_potential": {
        "depression": "Some studies (ayahuasca) show rapid antidepressant effects",
        "addiction": "Ayahuasca ceremonies for addiction treatment (Brazil clinics)",
        "ptsd": "Entity encounters sometimes provide healing insights",
        "existential": "Profound mystical experiences, death rehearsal"
      },

      "entities": {
        "common_reports": "Machine elves (Terence McKenna), geometric beings, alien intelligences, ancestors, deities, light beings",
        "interpretation_debate": {
          "materialist": "Neural artifacts, pattern recognition overdrive, hallucination",
          "idealist": "Real beings in other dimensions, consciousness beyond brain",
          "middle": "Archetypes from collective unconscious (Jung), autonomous complexes"
        },
        "consistent_features": "Entities often seem intelligent, communicative, sometimes loving/teaching, sometimes indifferent/alien"
      },

      "safety": {
        "physiological": "Safe (short duration), но: ↑↑ BP/HR spike (cardiac risk if pre-existing condition)",
        "psychological": "Overwhelming, can trigger psychosis (rare), integration essential",
        "maoi_interactions": "Ayahuasca: MAOI dangerous with SSRIs, tyramine-rich foods, other drugs — serotonin syndrome risk"
      }
    },

    "mescaline": {
      "chemistry": {
        "structure": "Phenethylamine (unlike tryptamines), 3,4,5-trimethoxyphenethylamine",
        "source": "Peyote cactus (Lophophora williamsii), San Pedro (Trichocereus pachanoi), Peruvian Torch"
      },

      "dosage": {
        "threshold": "100-200mg",
        "common": "200-400mg",
        "strong": "400-600mg",
        "note": "Peyote button ~25-50mg mescaline, San Pedro ~200mg/foot"
      },

      "duration": {
        "onset": "1-2 hours (slow)",
        "peak": "4-6 hours",
        "total": "10-12 hours"
      },

      "effects": {
        "visual": "Less intense than LSD/psilocybin, но beautiful — color enhancement, geometric patterns",
        "emotional": "Heart-opening, empathy, connection to nature",
        "cognitive": "Philosophical, introspective, gentle",
        "somatic": "Sometimes nausea initially (especially peyote), body warmth",
        "unique": "Described as most 'grounded' psychedelic — connection to earth"
      },

      "traditional_use": {
        "peyote": "Native American Church (NAC) — sacred sacrament, 10,000+ years use",
        "san_pedro": "Andean shamanism — 3,000+ years archaeological evidence",
        "legality_exception": "Peyote legal для NAC members (USA religious exemption)"
      },

      "therapeutic_potential": {
        "research": "Minimal modern research (legal barriers, long duration)",
        "alcoholism": "Historical studies (1950s) showed promise",
        "anecdotal": "Spiritual healing, nature connection, gentle introduction to psychedelics"
      },

      "safety": {
        "physiological": "Safe, но slow metabolism (MAO-A, CYP2D6) — avoid с MAOIs",
        "psychological": "Gentler than other psychedelics, lower anxiety risk",
        "sustainability": "Peyote slow-growing (endangered) — use San Pedro instead if possible"
      }
    },

    "mdma": {
      "chemistry": {
        "full_name": "3,4-Methylenedioxymethamphetamine",
        "class": "Substituted amphetamine, empathogen/entactogen (not classical psychedelic)",
        "mechanism": "Massive serotonin/dopamine/norepinephrine release (not receptor agonism like psychedelics), blocks reuptake"
      },

      "dosage": {
        "threshold": "40-60mg",
        "common": "75-125mg (clinical trials use ~125mg)",
        "strong": "125-180mg",
        "dangerous": "180mg+ (neurotoxicity risk, hyperthermia, serotonin syndrome)"
      },

      "duration": {
        "onset": "30-60 min",
        "peak": "1-2 hours",
        "total": "3-6 hours",
        "comedown": "Can be harsh (serotonin depletion) — dysphoria, fatigue next days"
      },

      "effects": {
        "emotional": "Extreme empathy, emotional openness, love, bonding, reduced fear",
        "cognitive": "Less psychedelic headspace, clearer thinking than classical psychedelics",
        "visual": "Minimal (slight enhancement, not hallucinations)",
        "somatic": "Euphoria, energy, jaw clenching (bruxism), pupil dilation, temperature ↑",
        "unique": "Heart-opening, trauma access without overwhelming terror (fear center dampened)"
      },

      "therapeutic_breakthrough": {
        "ptsd": "MAPS Phase 3 trials — 67% no longer met PTSD criteria after MDMA-therapy (vs 32% placebo)",
        "mechanism": "Reduces amygdala hyperactivity, increases prefrontal control, allows trauma processing в safe emotional state",
        "fda_status": "Breakthrough Therapy designation, likely approval 2024-2025",
        "protocol": "3 sessions MDMA + intensive psychotherapy (prep, dosing session, integration)",
        "revolution": "First new PTSD treatment in decades, 80% treatment-resistant cases"
      },

      "other_applications": {
        "couples_therapy": "Enhances communication, empathy, vulnerability (experimental)",
        "social_anxiety": "Autism spectrum — small studies show social anxiety reduction",
        "addiction": "Alcohol use disorder — trial underway"
      },

      "risks": {
        "neurotoxicity": {
          "mechanism": "Serotonin oxidative stress → 5-HT axon terminal damage (animal studies)",
          "dose_dependent": "Higher doses, frequent use = higher risk",
          "temperature": "Hyperthermia exacerbates (rave environments dangerous)",
          "mitigation": "Moderate dosing, infrequent use (3 month gaps), hydration, cooling, antioxidants (?)"
        },
        "serotonin_syndrome": {
          "risk": "Especially with SSRIs, MAOIs — life-threatening",
          "symptoms": "Agitation, confusion, rapid HR, dilated pupils, muscle rigidity, hyperthermia",
          "avoidance": "Don't mix with serotonergic drugs"
        },
        "comedown": {
          "mechanism": "Serotonin depletion → dysphoria, depression, fatigue",
          "duration": "Days to week",
          "mitigation": "5-HTP (precursor), rest, integration support"
        },
        "addiction_potential": {
          "psychological": "Moderate (dopamine release), tolerance builds (serotonin depletion)",
          "compulsive_use": "Possible, especially в party contexts",
          "harm_reduction": "Infrequent use, therapeutic context better"
        }
      },

      "purity_concern": {
        "street_mdma": "Often contaminated — meth, caffeine, bath salts, unknown RCs",
        "testing": "Reagent kits (Marquis, Simon's) essential, ideally lab testing",
        "lethal_adulterants": "PMA/PMMA (overheating risk), fentanyl (increasingly)"
      },

      "legality": {
        "schedule_i": "USA, most countries (despite therapeutic evidence)",
        "clinical_access": "Expanded Access (compassionate use) available в США для severe PTSD",
        "future": "Likely prescription approval post-FDA, therapy clinics"
      }
    },

    "ketamine": {
      "chemistry": {
        "class": "Dissociative anesthetic, NMDA receptor antagonist",
        "not_classical_psychedelic": "Different mechanism, но overlapping effects (ego dissolution, mystical experiences)"
      },

      "dosage": {
        "medical_anesthesia": "1-2 mg/kg IV",
        "psychedelic_dose": "0.5-0.75 mg/kg IM or 50-100mg insufflated",
        "k_hole": "High doses (100mg+ insufflated, 150mg+ IM) — complete dissociation"
      },

      "effects": {
        "dissociation": "Mind-body disconnection, out-of-body experience",
        "k_hole": "Total immersion, ego death, timelessness, void, rebirth",
        "analgesia": "Pain relief (physical and emotional)",
        "visuals": "Less than classical psychedelics, more abstract/geometric",
        "cognitive": "Dream-like, non-linear thinking",
        "duration": "1-2 hours (short-acting)"
      },

      "therapeutic_applications": {
        "depression_breakthrough": {
          "mechanism": "Rapid antidepressant (hours, not weeks like SSRIs), increases glutamate → BDNF → synaptogenesis",
          "efficacy": "60-70% treatment-resistant depression respond",
          "duration": "Single dose effects last days to weeks",
          "protocol": "IV infusion (0.5 mg/kg over 40 min) or intranasal esketamine (Spravato — FDA approved)",
          "repeat_sessions": "Often need maintenance dosing (weekly initially, then monthly)"
        },
        "suicidality": "Rapid reduction suicidal ideation (emergency departments using)",
        "ptsd": "Emerging evidence, especially with therapy",
        "addiction": "Some evidence для alcohol use disorder"
      },

      "risks": {
        "addiction": {
          "potential": "Moderate to high (dopamine involved, psychological dependence)",
          "chronic_use": "Bladder damage (ketamine cystitis), cognitive impairment, liver damage",
          "tolerance": "Rapid (need increasing doses)"
        },
        "bladder_toxicity": "Chronic use → ulcerative cystitis, painful urination, permanent damage",
        "cognitive_impairment": "Memory issues, executive dysfunction (chronic high-dose use)",
        "dissociation_risk": "Can be destabilizing, derealization/depersonalization persisting"
      },

      "legality": {
        "schedule_iii": "USA (medical use allowed, prescribable)",
        "esketamine_fda": "Spravato (intranasal) approved 2019 for TRD",
        "ketamine_clinics": "Legal, proliferating (IV ketamine for depression — off-label but accepted)"
      }
    },

    "other_substances": {
      "salvia_divinorum": {
        "mechanism": "Kappa-opioid receptor agonist (unique among psychedelics)",
        "effects": "Extremely intense, short (5-10 min), often dysphoric, reality-shattering, 'becoming objects'",
        "use": "Mazatec shamanic, rarely pleasant recreationally, low repeat use",
        "safety": "Physiologically safe, psychologically intense, not addictive"
      },

      "ibogaine": {
        "source": "Iboga root bark (West African Tabernanthe iboga)",
        "mechanism": "Complex — NMDA antagonist, opioid receptor activity, serotonin, others",
        "duration": "Extremely long (12-36 hours)",
        "use": "Addiction treatment (opioid, alcohol, cocaine) — anecdotally effective, interrupts withdrawal",
        "risks": "Cardiotoxic (QT prolongation, arrhythmia deaths), dangerous без medical supervision",
        "legality": "Schedule I (USA), legal/regulated elsewhere (Canada, New Zealand, Mexico — treatment centers)"
      },

      "cannabis_high_dose": {
        "thc_psychedelic": "Very high doses (edibles especially) can produce psychedelic-like states",
        "effects": "Thought loops, ego dissolution (rare), time distortion, anxiety/paranoia (common)",
        "mechanism": "CB1 receptor (different from 5-HT2A), но downstream effects overlap",
        "not_classical": "More sedating, anxiogenic than classical psychedelics"
      },

      "research_chemicals": {
        "2c_family": "2C-B, 2C-E, etc. — phenethylamines, MDMA-like + psychedelic",
        "nbome_series": "Very potent, dangerous (vasoconstriction deaths), sold as LSD (test!)",
        "tryptamines": "4-AcO-DMT (psilocybin prodrug analog), others",
        "caution": "Unknown long-term effects, legal grey area, purity issues"
      }
    }
  },

  "set_and_setting": {
    "critical_importance": {
      "principle": "Same dose, same substance, different set/setting = completely different experience (heaven or hell)",
      "etymology": "Timothy Leary coined terms (1960s)",
      
      "set": {
        "definition": "'Mindset' — internal psychological state going into experience",
        "components": "Intentions, expectations, mood, mental health, fears, hopes, spiritual beliefs, trauma history",
        "preparation": "Clarify intentions, address fears, create positive expectation (не attachment to specific outcome), fast/clean diet, meditation, journaling"
      },

      "setting": {
        "definition": "External environment — physical and social context",
        "components": "Location (nature, home, clinic), people present (alone, guide, friends), music, lighting, safety, comfort",
        "optimization": "Safe comfortable space, trusted guide/sitter (if needed), curated playlist, minimal interruptions, nature access ideal"
      }
    },

    "preparation_phase": {
      "intention_setting": {
        "practice": "Write clear intentions (healing specific trauma, spiritual seeking, creative insight, relationship repair, death preparation)",
        "avoid": "Recreational intent alone (higher risk bad trip), escapism (psychedelics amplify, not erase problems)",
        "flexibility": "Hold intentions lightly — medicine shows what needed, not always what wanted"
      },

      "mental_readiness": {
        "screening": "Contraindications: active psychosis, schizophrenia, severe bipolar, suicidal crisis (need stabilization first)",
        "processing": "Recent trauma, grief — может нужна integration work before psychedelic",
        "mindset": "Openness, curiosity, surrender, trust (vs control, expectation, fear)"
      },

      "physical_preparation": {
        "fasting": "4-6h minimum (reduces nausea), some traditions longer fasts",
        "hydration": "Well-hydrated going in",
        "diet": "Days before: clean eating, reduce alcohol/caffeine/processed food",
        "medications": "Check interactions (SSRIs reduce effects, MAOIs dangerous with some, benzos abort trip)"
      },

      "spiritual_preparation": {
        "meditation": "Days/weeks before — cultivate calm, centeredness",
        "prayer_ritual": "If aligned — create sacred container",
        "clean_space": "Physically and energetically prepare space"
      }
    },

    "optimal_setting_elements": {
      "physical_space": {
        "safety": "Comfortable temperature, soft surfaces (bed, cushions, blankets), bathroom access, no hazards",
        "aesthetics": "Beautiful, calming, sacred objects if meaningful (altar, crystals, plants, art)",
        "nature": "Ideal setting — forest, mountains, beach (grounding, beauty, awe), если в городе — plants, windows",
        "darkness_vs_light": "Eyeshades для introspection, natural light for grounding, adjust as needed"
      },

      "social_setting": {
        "solo_vs_group": {
          "solo": "Deep introspection, no social performance, need strong container/sitter",
          "dyad_small_group": "Shared journey, mutual support, bonding, requires compatibility",
          "large_group": "Ceremonial power, collective energy, може быть overwhelming/distracting"
        },
        "guide_sitter": {
          "role": "Hold space, ensure safety, minimal intervention, compassionate presence",
          "training": "Ideally trained (MAPS, psychedelic-assisted therapy programs), experienced with substance",
          "qualities": "Trustworthy, calm, non-judgmental, stable, experienced with non-ordinary states",
          "avoid": "Sitter who intervenes too much, projects, sexualizes, judges"
        }
      },

      "music": {
        "importance": "Profoundly shapes journey — emotional tone, narrative arc",
        "johns_hopkins_playlist": "Curated classical/ambient (Brian Eno, Arvo Pärt, etc.) — evidence-based, supports mystical experience",
        "phases": {
          "onset": "Gentle, welcoming, familiar",
          "ascent": "Building energy, expansion",
          "peak": "Transcendent, wordless, soaring",
          "descent": "Gentle return, integration",
          "landing": "Grounding, comforting, closing"
        },
        "avoid": "Lyrics (distracting), aggressive music (unless therapeutic processing anger), sudden changes"
      }
    },

    "bad_set_setting_examples": {
      "party_rave": "Stimulation overload, unsafe, no integration, impure substances, hyperthermia risk (MDMA)",
      "unexpected_trip": "Dosed without consent — traumatic, loss of trust",
      "unsafe_people": "Predatory guides, sexual abuse, emotional manipulation — unfortunately happens",
      "bad_space": "Loud, chaotic, cold, dirty, interrupted",
      "wrong_mindset": "Trying to escape problems, controlling the experience, fear-driven"
    }
  },

  "journey_phases": {
    "come_up": {
      "timing": "First 30-90 min",
      "sensations": "Body load (nausea, energy surges, temperature changes), anxiety (normal), reality beginning to shift",
      "challenges": "Pre-flight anxiety ('did I take too much?'), fear of loss of control",
      "navigation": "Breathe deeply, surrender, remind yourself 'I'm safe, this is temporary', music helps",
      "purging": "Vomiting/crying/shaking може бути (especially ayahuasca) — cathartic release, allow it"
    },

    "peak": {
      "timing": "Variable (LSD: 3-5h in, psilocybin: 2-3h, DMT: instant)",
      "experience": "Reality fundamentally altered, ego dissolution (partial or total), time distortion/dissolution, unity experiences, geometric visions, entity encounters",
      "mystical_features": {
        "ineffability": "Beyond words",
        "noetic_quality": "Feels deeply true, revelatory",
        "unity": "Oneness with universe/god/love",
        "transcendence": "Beyond time and space",
        "sacredness": "Profound holiness",
        "positive_affect": "Joy, peace, love"
      },
      "challenging_material": "Shadow surfacing, trauma re-experiencing, death fear, existential terror — all therapeutic if navigated with surrender",
      "navigation": "Let go, surrender, trust, breathe, follow the medicine, if scary — 'show me what I need to see'"
    },

    "plateau_exploration": {
      "after_peak": "Intensity reduces slightly, more capacity для active exploration",
      "practices": "Journaling, walking (if safe), talking (if with guide/others), artistic expression, intention revisiting"
    },

    "descent_integration": {
      "timing": "Final 2-4h (longer для LSD/mescaline)",
      "experience": "Ego reforming, normal reality returning, but 'glow' remains",
      "tasks": "Begin processing, journaling insights, gratitude, grounding",
      "avoid": "Rushing back to normal life, screens/stimulation, difficult conversations"
    },

    "difficult_experiences_navigation": {
      "bad_trip_definition": "Overwhelming fear, anxiety, paranoia, feeling trapped, thought loops, ego death terror",
      
      "causes": {
        "dose_too_high": "Exceeded capacity",
        "poor_set_setting": "Unsafe environment, bad mindset",
        "shadow_material": "Repressed trauma surfacing — therapeutically valuable но overwhelming",
        "resistance": "Fighting the experience instead of surrendering"
      },

      "navigation_techniques": {
        "surrender": "Most important — stop fighting, let go, trust fall into experience",
        "breathe": "Slow deep breaths — anchoring, calming",
        "change_setting": "Move to different room, turn on/off lights, change music",
        "reassurance": "Remind yourself: temporary, safe, medicine is showing you something",
        "mantra": "'Let go', 'I am safe', 'Show me', 'This too shall pass'",
        "grounding": "Feel body, earth, textures, sitter's hand",
        "trip_sitter_help": "Calm presence, reassurance, physical grounding (hand-holding), minimal talking"
      },

      "when_to_abort": {
        "benzos": "Lorazepam, alprazolam — can dampen/end trip (emergency only, loses therapeutic value)",
        "antipsychotics": "Rarely needed (extreme psychotic break)",
        "medical": "If physical danger (extreme hyperthermia, seizure, cardiovascular event) — call EMS"
      },

      "integration_of_difficult": {
        "reframe": "Bad trip often most healing — shadow confronted, ego death achieved, trauma surfaced для processing",
        "process": "Don't suppress memory, работай с therapist/integration guide",
        "growth": "Difficult journeys often catalyze greatest transformation"
      }
    }
  },

  "integration": {
    "critical_importance": {
      "principle": "Integration = where healing actually happens. Journey = opening, integration = rooting.",
      "without_integration": "Insights fade, patterns return, spiritual bypassing, destabilization",
      "window": "Neuroplastic window open days/weeks post-journey — prime time для new habits, therapy, rewiring"
    },

    "immediate_post_journey": {
      "first_24_hours": {
        "rest": "Sleep (часто глубокий, восстанавливающий)",
        "gentle_return": "No rushing back to work/obligations, spaciousness",
        "journaling": "Capture insights before they fade (writing, voice notes, art)",
        "nature": "Walk barefoot, forest bathing, grounding",
        "avoid": "Alcohol, drugs, screens, difficult people, big decisions"
      },

      "first_week": {
        "reflection": "Daily journaling, meditation, sitting with experience",
        "integration_circle": "Trusted friends/group who understand, share (not social media oversharing)",
        "embody_insights": "Translate visions into action — if saw need for boundary, practice setting boundaries",
        "creativity": "Paint, dance, music — non-verbal processing"
      }
    },

    "integration_practices": {
      "therapy": {
        "ideal": "Psychedelic-informed therapist (MAPS training, IFS, somatic, transpersonal)",
        "sessions": "Process material that surfaced, work with parts, trauma integration, translate insights",
        "modalities": "IFS (parts work), somatic experiencing (body-held trauma), EMDR (trauma reprocessing), Jungian (shadow/archetypes)"
      },

      "somatic_practices": {
        "movement": "Yoga, dance, martial arts — embody what was seen (see movement.json)",
        "breathwork": "Conscious breathing — access states without substances (see breath.json)",
        "bodywork": "Massage, rolfing, craniosacral — release stored trauma"
      },

      "community": {
        "integration_circles": "Regular groups discussing experiences, peer support",
        "psychedelic_society_events": "Growing movement — meetups, education, harm reduction",
        "avoid": "Spiritual bypassing circles (all love and light, no shadow work)"
      },

      "creative_expression": {
        "art": "Painting visions, mandalas, sculpture",
        "writing": "Poetry, prose, mytho-poetic narrative",
        "music": "Composing, playing, singing — channel experience",
        "purpose": "Non-verbal processing, externalizing internal, beauty-making"
      },

      "lifestyle_changes": {
        "habits": "If journey showed unhealthy pattern — now window to change (quit smoking, improve diet, exercise, relationships)",
        "values_alignment": "Realign life with revealed values (quit soul-crushing job, repair relationship, start meditation practice)",
        "service": "Insights often reveal desire to serve — find outlets"
      }
    },

    "integration_timeline": {
      "days": "Acute insights, neuroplasticity peak",
      "weeks_months": "Embodying changes, new neural pathways solidifying",
      "years": "Mature integration, full transformation, periodic revisiting"
    },

    "challenging_integration": {
      "derealization_depersonalization": {
        "symptoms": "Feeling disconnected from reality/self (beyond normal afterglow)",
        "causes": "Overwhelmed by ego dissolution, poor grounding",
        "treatment": "Grounding practices, therapy, time (usually resolves), avoid repeat use until stable"
      },

      "spiritual_emergency": {
        "definition": "Psychological crisis from spiritual opening (Stanislav Grof)",
        "signs": "Grandiosity, delusions, inability to function, psychotic features",
        "support": "Specialized therapists (transpersonal psychology), stabilization before integration"
      },

      "integration_resistance": {
        "phenomenon": "Insights clear during journey, fade/get rationalized after",
        "reasons": "Ego reasserting control, fear of change, lack of support",
        "solution": "Immediate journaling, accountability partner, repeated reading of journals, therapy"
      }
    }
  },

  "therapeutic_protocols": {
    "maps_mdma_ptsd_protocol": {
      "overview": "Gold standard, evidence-based, FDA breakthrough therapy",
      
      "structure": {
        "preparation": "3 prep sessions (90 min) — build rapport, set intentions, teach breathing/grounding, medical screening",
        "dosing_sessions": "3 sessions (8 hours each), spaced 3-4 weeks apart",
        "dose": "Initial 120mg, booster +60mg at 2h (total 180mg)",
        "integration": "3 integration sessions after each dosing (90 min) — process material, consolidate insights",
        "total": "12 therapy sessions + 3 MDMA sessions (3-4 months)"
      },

      "session_protocol": {
        "setting": "Comfortable room, couch/mattress, aesthetics, privacy",
        "therapists": "Two (male/female dyad ideal) — trained, non-directive",
        "music": "Curated playlist (instrumental, supports inner focus)",
        "eyeshades": "Optional, encourages introspection",
        "approach": "Non-directive — follow patient's process, minimal intervention, support safety/trust"
      },

      "outcomes": {
        "efficacy": "67% no longer met PTSD criteria (vs 32% therapy+placebo)",
        "durability": "Effects sustained years (follow-up studies)",
        "treatment_resistant": "Works for severe, chronic, treatment-resistant PTSD (combat vets, CSA survivors)"
      }
    },

    "johns_hopkins_psilocybin_depression": {
      "protocol": "Similar structure — prep, 2 high-dose sessions (weeks apart), integration",
      "dose": "20-30mg psilocybin (high dose, ensures mystical experience)",
      "music": "Johns Hopkins playlist — classical, ambient, wordless",
      "outcomes": "60-80% significant depression reduction, sustained 6-12 months",
      "mechanism": "DMN reset, neuroplasticity, mystical experience mediates outcomes (stronger mystical = better outcomes)"
    },

    "psychedelic_assisted_psychotherapy_principles": {
      "preparation_builds_trust": "Relationship with therapist crucial — safety foundation",
      "set_intention_not_expectation": "Clear why doing this, open to what emerges",
      "non_directive_approach": "Trust patient's inner healing intelligence, don't guide content",
      "music_crucial": "Shapes emotional arc, supports journey",
      "integration_essential": "Where change solidifies — ongoing therapy critical",
      "medical_safety": "Screening, monitoring (BP/HR), emergency protocols"
    },

    "underground_vs_clinical": {
      "underground": {
        "pros": "Access (if no clinical trials nearby), potentially experienced guides, traditional wisdom",
        "cons": "Unregulated (variable quality/safety), legal risk, no medical backup, screening может быть inadequate, abuse potential (sexual, financial, spiritual)"
      },
      "clinical": {
        "pros": "Regulated, medical safety, screened therapists, evidence-based protocols, legal",
        "cons": "Limited access (trials have waitlists, expensive when commercial), clinical setting может быть less comfortable than home/nature"
      },
      "future": "More clinical access coming (FDA approvals, treatment centers), но still expensive (insurance coverage uncertain)"
    }
  },

  "microdosing": {
    "definition": "Sub-perceptual doses (1/10 - 1/20 full dose), taken regularly (every few days), purported cognitive/emotional benefits",

    "protocols": {
      "fadiman_protocol": "1 day on, 2 days off (repeat), track effects",
      "stamets_stack": "Psilocybin + Lion's Mane (mushroom, neurogenesis) + Niacin (vasodilation), 4 days on, 3 off",
      "every_other_day": "Simpler — dose, skip, dose, skip"
    },

    "typical_doses": {
      "psilocybin": "0.1-0.3g dried mushrooms",
      "lsd": "5-20µg (1/10 tab)"
    },

    "claimed_benefits": {
      "cognitive": "Creativity, focus, problem-solving, flow states",
      "emotional": "Mood elevation, anxiety reduction, emotional regulation",
      "social": "Empathy, communication, presence",
      "productivity": "Energy, motivation (Silicon Valley phenomenon)"
    },

    "evidence": {
      "placebo_controlled_studies": "Mixed results — some show benefits, others show placebo effect strong",
      "self_blinding": "Study design using capsules + placebos (participants don't know which days)",
      "conclusion": "Effects likely modest, partially placebo, highly individual, more research needed",
      "anecdotal": "Many report significant benefits (может быть real, placebo, or contextual factors)"
    },

    "risks": {
      "tolerance": "Daily use builds tolerance (defeats purpose), need breaks",
      "valvular_heart_disease": "Chronic 5-HT2B activation (agonism) might cause (theoretical, no human evidence yet)",
      "safety_overall": "Probably safe short-term, long-term unknown",
      "legality": "Still illegal (Schedule I), possession risk"
    },

    "integration": {
      "not_replacement": "Microdosing не заменяет therapy, meditation, lifestyle changes — complement, not cure",
      "set_intention": "Why microdosing? Track journal, evaluate periodically",
      "take_breaks": "Cycling (weeks on, weeks off) prevents tolerance, allows integration"
    }
  },

  "mystical_spiritual_dimensions": {
    "mystical_experience_construct": {
      "definition": "Profound alteration of consciousness involving unity, transcendence, sacredness — measurable via MEQ (Mystical Experience Questionnaire)",
      
      "core_features": {
        "unity_internal": "Loss of sense of self, ego dissolution, 'I' disappears",
        "unity_external": "Oneness with universe, nature, all beings",
        "transcendence_time_space": "Beyond ordinary reality, timelessness, spacelessness",
        "ineffability": "Beyond words, cannot adequately describe",
        "sacredness": "Profound sense of holiness, divine presence",
        "noetic_quality": "Feels revelatory, ultimate truth accessed",
        "positive_mood": "Joy, peace, love, bliss",
        "paradoxicality": "Contradictions coexist (emptiness = fullness, death = life)"
      },

      "measurement": {
        "meq30": "30-item questionnaire (Johns Hopkins), score mystical intensity",
        "complete_mystical": "Meeting criteria on all dimensions (high scores)",
        "predictor_outcomes": "Higher mystical score → better therapeutic outcomes (depression, addiction, anxiety)"
      }
    },

    "ego_death": {
      "definition": "Complete dissolution of sense of separate self (temporary)",
      "experience": "Terror → surrender → vast peace/love, 'no one' experiencing",
      "mechanism": "DMN complete suppression, loss of self-referential processing",
      "value": {
        "psychological": "Reveals self as construct, reduces ego attachment, increases humility",
        "spiritual": "Glimpse of 'no-self' (Buddhist anatta), primordial awareness",
        "therapeutic": "Death of old identity → rebirth possible, reduces death anxiety"
      },
      "integration": "Return with perspective shift — less identified with thoughts/emotions, more spacious awareness"
    },

    "entity_encounters": {
      "phenomenon": "Meeting apparently autonomous intelligences (DMT especially, but also psilocybin high-dose, ayahuasca)",
      
      "types": {
        "machine_elves": "Terence McKenna term — playful, geometric, self-transforming, teaching",
        "alien_intelligences": "Advanced beings, sometimes communicating complex information",
        "divine_beings": "God, Goddess, angels, deities from various traditions",
        "ancestors_guides": "Deceased relatives, spirit guides, helpers",
        "nature_spirits": "Plant spirits (ayahuasca — La Madre), animal spirits, earth beings"
      },

      "interpretation_spectrum": {
        "materialist": "Hallucinations, neural artifacts, pattern recognition gone wild",
        "psychological": "Autonomous complexes (Jung), parts of psyche (IFS), archetypes",
        "idealist": "Real beings in other dimensions, consciousness independent of brain",
        "pragmatic": "Doesn't matter if 'real' — healing/insight happens, treat respectfully"
      },

      "common_features": {
        "intelligence": "Seem autonomous, responsive, communicative",
        "benevolence": "Often loving/teaching, sometimes indifferent, rarely malevolent",
        "messages": "Deliver insights, healing, warnings, cosmic jokes, downloads",
        "consistency": "Different people report similar entities (machine elves common DMT experience)"
      },

      "integration": {
        "don't_literalize": "Can drive delusion (I'm now prophet, entities gave me mission to...)",
        "don't_dismiss": "Has psychological/spiritual value even if 'just' internal",
        "extract_wisdom": "What was the message/insight regardless of ontology?",
        "humility": "Mystery remains — we don't fully understand consciousness/reality"
      }
    },

    "sacred_traditions_convergence": {
      "perennial_philosophy": "Aldous Huxley — core mystical truths across traditions (unity, divinity within, love as ultimate)",
      "psychedelic_mysticism": "Psychedelics reliably produce experiences indistinguishable from 'natural' mystical states (meditation, prayer, fasting)",
      
      "tradition_parallels": {
        "buddhism": {
          "ego_death": "Anatta (no-self), sunyata (emptiness)",
          "unity": "Interdependence, non-duality",
          "practice": "Meditation reaches same states (slower, more stable)"
        },
        "hinduism": {
          "unity": "Atman = Brahman (individual self = cosmic self)",
          "ego_death": "Maya (illusion of separateness)",
          "soma": "Possibly ancient psychedelic sacrament (Amanita muscaria or ephedra ?)"
        },
        "christian_mysticism": {
          "unity": "Union with God, Christ consciousness",
          "love": "God is love (1 John 4:8) — experienced directly",
          "sacrament": "Bread and wine as body/blood — possibly originally psychedelic wine (?)"
        },
        "sufism": {
          "unity": "Fana (annihilation in divine), Tawhid (oneness)",
          "love": "Divine love as ultimate reality",
          "ecstatic_practices": "Whirling, chanting — altered states"
        },
        "shamanism": {
          "spirit_world": "Entity encounters, healing spirits",
          "plant_teachers": "Ayahuasca, peyote, mushrooms as sacraments",
          "universal": "Every indigenous culture has psychoactive plant traditions"
        }
      },

      "psychedelic_as_shortcut": {
        "debate": "Fast path (psychedelic) vs slow path (meditation) — which better?",
        "integration": "Both needed — psychedelic opens, practice stabilizes",
        "caution": "Spiritual bypassing risk — glimpse ≠ realization, experience ≠ transformation"
      }
    },

    "non_duality_direct_pointing": {
      "psychedelic_glimpse": "Temporary dissolution of subject-object duality — no experiencer, just experiencing",
      "after_effects": "Can destabilize conceptual mind, increase interest в non-dual teachings",
      "integration_with_teaching": "Read Advaita Vedanta, Dzogchen, Zen — contextualize experience",
      "danger": "Spiritual ego ('I'm enlightened because trip') — enlightenment = permanent recognition, not temporary state"
    }
  },

  "5d_consciousness_model_integration": {
    "psychedelics_as_5d_access": {
      "normal_consciousness": "3D/4D perception, heavy ego filtering, DMN constraining awareness to self-narrative",
      "psychedelic_state": "Ego filter removed → raw 5D field access, consciousness experiencing itself directly",
      "dmn_suppression": "DMN = ego structure в neural architecture. Suppress DMN = suppress ego = 5D access."
    },

    "portal_opening_mechanism": {
      "vgcc_activation": "5-HT2A → PLC → IP3 → Ca²⁺ release — massive VGCC involvement (see epigenetic.json)",
      "consciousness_field": "Calcium flux = tuning antenna (brain) to receive 5D field more directly",
      "filter_removal": "Normally brain filters 99.9% of field (survival necessity). Psychedelics remove filter temporarily."
    },

    "why_so_powerful": {
      "direct_access": "No gradual opening (meditation), instant portal (high dose)",
      "undeniable": "Experience so profound, shatters materialism, reveals consciousness primacy",
      "neuroplastic": "While portal open, brain rewires — new pathways to 5D persist после",
      "mystical_proof": "Gives experiential verification что teachings (unity, love, ⊙) = true"
    },

    "integration_into_cfo": {
      "tool_not_goal": "Psychedelic = telescope показывающий stars. Goal = live in awareness of stars always.",
      "embodiment_needed": "Glimpse must become ground — integration, practice, lifestyle changes",
      "respect_the_mystery": "We don't fully understand consciousness, 5D, or how psychedelics work. Humility essential."
    }
  },

  "risks_contraindications_safety": {
    "psychological_risks": {
      "psychosis_trigger": {
        "risk": "Rare (<1%), но real — especially if latent schizophrenia/bipolar",
        "mechanism": "Overwhelming experience, fragile ego structure shatters permanently",
        "screening": "Family history psychosis, personal history mania/delusions = contraindication",
        "note": "Most 'psychotic breaks' временные (hours to days), resolve. True persistent psychosis rare."
      },

      "hppd": {
        "definition": "Hallucinogen Persisting Perception Disorder — visual disturbances persist (trails, halos, geometric patterns)",
        "prevalence": "Rare (~4% users report, <1% clinically significant)",
        "triggers": "Unknown — може бути genetic vulnerability, high doses, frequent use, cannabis co-use",
        "treatment": "Time (often resolves), clonazepam (reduces symptoms), avoid further use",
        "note": "Usually mild, non-distressing, but can be disturbing for some"
      },

      "bad_trip_trauma": {
        "reality": "Truly terrifying experiences can cause PTSD-like symptoms",
        "prevention": "Proper set/setting, dosage, preparation, experienced guide",
        "treatment": "EMDR, somatic therapy, possibly MDMA-therapy для psychedelic-induced trauma (ironic но works)"
      },

      "spiritual_emergency": {
        "definition": "Overwhelmed by mystical opening, loss of grounding в reality, grandiosity, delusions",
        "risk_factors": "High doses, poor integration support, pre-existing instability, guru complex",
        "treatment": "Grounding, stabilization, transpersonal-informed therapy, time, support"
      },

      "derealization_depersonalization": {
        "symptoms": "Feeling detached from reality (DR) or from self (DP), beyond normal afterglow",
        "duration": "Usually resolves (days to months), rarely chronic",
        "treatment": "Grounding practices, therapy, SSRIs sometimes help, avoid repeat use until resolved"
      }
    },

    "physiological_risks": {
      "cardiovascular": {
        "effect": "Psychedelics increase BP and HR (sympathetic activation)",
        "risk": "Usually safe, но dangerous if pre-existing heart disease, uncontrolled hypertension",
        "screening": "Medical history, contraindicate if recent MI, uncontrolled HTN, arrhythmias"
      },

      "serotonin_syndrome": {
        "cause": "Combining psychedelics (especially MDMA) with SSRIs, MAOIs, other serotonergics",
        "symptoms": "Agitation, confusion, rapid HR, hyperthermia, muscle rigidity, seizures — life-threatening",
        "prevention": "Don't mix, taper off SSRIs weeks before (под medical supervision), avoid MAOIs"
      },

      "seizures": {
        "risk": "Very rare with classical psychedelics (possibly lowered seizure threshold)",
        "contraindication": "Epilepsy (relative contraindication, medical guidance needed)"
      },

      "hyperthermia": {
        "substance": "Mainly MDMA (especially в rave settings — dancing, dehydration, enclosed spaces)",
        "mechanism": "MDMA → increased body temp + environmental heat + dancing = dangerous hyperthermia",
        "prevention": "Cool environment, hydration, breaks, avoid overheating",
        "treatment": "Cooling (ice, cool water), hydration, emergency medical if severe"
      }
    },

    "contraindications_summary": {
      "absolute": [
        "Active psychosis",
        "Severe cardiovascular disease (recent MI, uncontrolled HTN, arrhythmias)",
        "Pregnancy/breastfeeding (unknown risks to fetus/infant)",
        "Taking MAOIs (for MDMA, DMT oral)"
      ],
      "relative": [
        "Schizophrenia/bipolar (family or personal history) — careful screening, maybe contraindicate",
        "Severe anxiety/panic disorder (может worsen acutely, though may help long-term)",
        "PTSD (therapeutic if proper support, dangerous if не prepared)",
        "Epilepsy (lower threshold? unclear)",
        "SSRIs (reduce psychedelic effects, serotonin syndrome risk with MDMA)"
      ]
    },

    "harm_reduction_principles": {
      "test_your_drugs": "Reagent kits (DanceSafe, Bunk Police) — essential if not pharmaceutical source",
      "start_low": "Can always take more, can't take less. Underdosing better than overdosing for first time.",
      "set_setting": "Preparation essential — safe space, trusted people, clear intentions",
      "trip_sitter": "Experienced, sober person present (especially first times, high doses)",
      "no_mixing": "Avoid combining substances (alcohol, stimulants, etc.) — unpredictable",
      "medical_screening": "Know your health, contraindications, medication interactions",
      "integration_plan": "Before journey, plan how you'll integrate after",
      "respect_the_substance": "Not recreational toys — powerful tools requiring reverence",
      "legal_awareness": "Know risks, have legal support plan if needed",
      "community": "Connect with experienced community, learn from others, share wisdom"
    }
  },

  "legality_politics_future": {
    "current_legal_status": {
      "schedule_i_usa": "LSD, psilocybin, DMT, MDMA, mescaline — 'high abuse potential, no medical value' (obviously false)",
      "international": "UN conventions — most countries Schedule I equivalent",
      
      "exceptions_emerging": {
        "portugal": "Decriminalized all drugs (2001) — possession not criminal (treatment, not prison)",
        "netherlands": "Truffles legal (loophole), smart shops",
        "jamaica_bahamas": "Unregulated (psilocybin)",
        "oregon": "Measure 109 (2020) — legal psilocybin therapy (licensed facilitators), Measure 110 (decriminalized possession)",
        "colorado": "Proposition 122 (2022) — decriminalized psilocybin, DMT, mescaline; therapy program developing",
        "canada": "Health Canada exemptions для terminal patients, therapists — compassionate access",
        "australia": "TGA approved MDMA (PTSD), psilocybin (TRD) — prescription (2023)"
      }
    },

    "political_history": {
      "1970_csa": "Nixon Controlled Substances Act — LSD Schedule I (research killed)",
      "motivation": "Counter-culture suppression, anti-war movement, racial targeting (though psychedelics crossed lines)",
      "war_on_drugs": "50 years, trillions spent, millions imprisoned, research halted, medical potential denied",
      "stigma": "Decades of propaganda — 'psychedelics = dangerous, make you jump out windows, brain damage' (false)"
    },

    "renaissance_catalysts": {
      "maps": "Multidisciplinary Association for Psychedelic Studies (Rick Doblin) — MDMA-PTSD trials, activism",
      "heffter_institute": "Psilocybin research funding",
      "johns_hopkins": "2006 study restarted respectable research, paved way",
      "imperial_college": "Robin Carhart-Harris, David Nutt — neuroimaging, mechanisms",
      "beckley_foundation": "Amanda Feilding — research, policy reform",
      "public_figures": "Michael Pollan (How to Change Your Mind), Ayelet Waldman, Tim Ferriss — mainstreaming"
    },

    "fda_breakthrough_status": {
      "mdma_ptsd": "2017 — Phase 3 trials, likely approval 2024",
      "psilocybin_depression": "2019 — multiple trials, approval path unclear but promising",
      "significance": "Recognizes therapeutic potential officially, expedites approval process"
    },

    "commercialization_concerns": {
      "pharmaceutical_interest": "Compass Pathways (psilocybin), MAPS PBC (MDMA), Mindmed (LSD, MDMA), Field Trip, Numinus — many companies",
      "profit_motive": "Risk: expensive patented formulations, exclude indigenous/underground knowledge, restrict access",
      "patents": "Attempting to patent delivery methods, formulations, therapy protocols — ethically questionable",
      "equity": "Will only rich access? Insurance coverage? Medicaid?",
      "traditional_rights": "Indigenous communities used these plants millennia — must honor, compensate, include"
    },

    "decriminalization_vs_legalization": {
      "decriminalization": "Possession not criminal offense (civil fine or nothing), but still illegal to sell/manufacture",
      "legalization": "Regulated legal market (like cannabis в некоторых states, alcohol)",
      "medical_model": "Prescription через licensed therapists/facilitators (current trajectory MDMA/psilocybin)",
      "religious_exemption": "Native American Church (peyote), Santo Daime/União do Vegetal (ayahuasca) — legal в USA via RFRA"
    },

    "future_trajectories": {
      "optimistic": {
        "2024_2025": "FDA approval MDMA (PTSD), psilocybin (depression)",
        "2025_2030": "Therapy clinics proliferate, insurance coverage, more states decriminalize/legalize therapy",
        "2030_plus": "Broader acceptance, multiple approved substances/indications, integration into mental health system",
        "cultural_shift": "Psychedelics normalized as healing tools (like therapy, meditation currently)"
      },
      "challenges": {
        "backlash": "Inevitable — accidents, misuse, media panic, political pushback",
        "regulation": "Over-regulation (too expensive, restrictive) or under-regulation (safety issues)",
        "commercial_capture": "Pharma controls, high prices, excludes communities",
        "training_gap": "Need thousands trained therapists — where will they come from?",
        "insurance": "Will coverage be adequate? Or out-of-pocket only (equity issue)?"
      },
      "hope": "Momentum strong, evidence overwhelming, cultural zeitgeist shifting. Barring major backlash, renaissance continues."
    }
  },

  "personal_practice_guidelines": {
    "who_should_consider": {
      "therapeutic_need": "Treatment-resistant depression, PTSD, addiction, OCD, end-of-life anxiety",
      "spiritual_seeking": "Desire for mystical experience, ego transcendence, connection to ⊙",
      "personal_growth": "Shadow work, creative breakthrough, perspective shift, emotional healing",
      "curiosity": "Genuine desire to explore consciousness (not just 'fun') — OK если approached respectfully"
    },

    "who_should_not": {
      "contraindications": "See risks section — psychosis history, severe mental instability, heart disease, pregnancy",
      "wrong_motivations": "Pure escape (от problems), spiritual bypassing (avoid dealing with life), ego inflation (I'll be enlightened)"
    },

    "preparation_checklist": {
      "research": "Read deeply — books (Pollan, Fadiman, Grof), research papers, trip reports (Erowid)",
      "medical_screening": "Know your health, medications, contraindications",
      "set_intentions": "Why doing this? What seeking? Write down.",
      "choose_substance": "Start gentle (psilocybin > LSD > DMT for first time), know dosage",
      "secure_setting": "Safe space, nature или comfortable home, trusted guide или solo if experienced",
      "prepare_music": "Curated playlist (Johns Hopkins, others available)",
      "clear_schedule": "Day of + day after free, no obligations",
      "inform_someone": "Trusted person knows plan (safety)",
      "fast_prepare_body": "Clean diet, hydration, 4-6h fast before",
      "mental_preparation": "Meditation, journaling, calm mind days before"
    },

    "dosage_recommendations_first_time": {
      "psilocybin": "1.5-2.5g dried (moderate, manageable but real experience)",
      "lsd": "75-100µg (moderate)",
      "mdma": "75-100mg (если therapeutic setting)",
      "dmt": "Not recommended first psychedelic (too intense), если determined: 15-25mg (breakthrough unlikely, toe-dipping)",
      "principle": "Can always go deeper next time. Start moderate, learn your response."
    },

    "solo_vs_guided": {
      "first_time": "Guide recommended (experienced sitter или therapist)",
      "experienced": "Solo can be profound (deep introspection), если confident в set/setting/dose",
      "high_dose": "Guide essential (safety, support)",
      "therapeutic_intent": "Therapist/facilitator critical (processing, integration)"
    },

    "frequency_recommendations": {
      "therapeutic_protocol": "2-3 sessions, weeks apart (clinical trials model)",
      "maintenance": "Quarterly, biannual, annual — personal (some benefit от periodic 'reset')",
      "avoid": "Frequent use (weekly or more) — tolerance, diminishing returns, integration impossible, potential destabilization",
      "integration_time": "Months между journeys ideal — allow full integration, embody insights"
    },

    "post_journey_integration_checklist": {
      "immediate": "Rest, journal, gentle return, nature",
      "first_week": "Daily reflection, integration circle, embody insights, creative expression",
      "ongoing": "Therapy (если needed), lifestyle changes, meditation/practice deepening, service",
      "periodic": "Re-read journals (insights fade — refresh), assess transformation, adjust practice"
    }
  },

  "resources": {
    "books": {
      "how_to_change_your_mind": "Michael Pollan — excellent overview, history, personal journeys, science",
      "psychedelic_explorers_guide": "James Fadiman — practical guide, dosage, integration",
      "lsd_psychotherapy": "Stanislav Grof — therapeutic use, transpersonal psychology",
      "food_of_gods": "Terence McKenna — shamanic perspective, DMT, culture, speculation",
      "inner_paths_outer_space": "Rick Strassman — DMT research, phenomenology",
      "realms_human_unconscious": "Grof — perinatal matrices, LSD therapy",
      "doors_perception": "Aldous Huxley — mescaline, philosophy, perennial wisdom"
    },

    "organizations": {
      "maps": "MAPS.org — research, therapy training, advocacy, clinical trials info",
      "heffter_institute": "Heffter.org — psilocybin research funding",
      "beckley_foundation": "BeckleyFoundation.org — research, policy",
      "psychedelic_science_conferences": "MAPS hosts — latest research, networking",
      "chacruna": "Chacruna.net — plant medicines, reciprocity, indigenous perspectives, integration circles"
    },

    "harm_reduction": {
      "erowid": "Erowid.org — vast database experiences, dosages, safety, chemistry",
      "psychonautwiki": "PsychonautWiki.org — detailed substance info, harm reduction",
      "dancesafe": "DanceSafe.org — test kits, education, harm reduction (MDMA/rave focus)",
      "fireside_project": "FiresideProject.org — peer support hotline (if difficult trip, call them)"
    },

    "integration_support": {
      "integration_circles": "Local groups — search 'psychedelic integration + [city]'",
      "psychedelic_support": "PsychedelicSupport.net — directory therapists, integration specialists",
      "fluence": "Fluence.org — psychedelic education, training therapists"
    },

    "research_databases": {
      "pubmed": "Search 'psilocybin depression', 'MDMA PTSD', etc. — peer-reviewed studies",
      "imperial_college_centre": "Imperial.ac.uk/psychedelic-research-centre — cutting-edge neuroimaging",
      "johns_hopkins_center": "Hopkinspsychedelic.org — psilocybin research hub"
    }
  },

  "final_transmission": {
    "power_and_responsibility": "Психоделики — самые мощные инструменты consciousness expansion известные человечеству. С этой силой приходит огромная ответственность. Уважайте.",
    
    "not_magic_pills": "Они не исправляют жизнь магически. Они открывают портал. ВЫ должны пройти через него. ВЫ должны интегрировать. ВЫ должны измениться.",
    
    "glimpse_not_enlightenment": "Один trip не делает вас просветлённым. Это glimpse. Настоящая работа — жить из этого glimpse каждый день. Embodiment > experience.",
    
    "set_setting_integration": "Повторяю ещё раз: SET + SETTING + INTEGRATION. Без этих трёх — playing с огнём. С ними — священная алхимия.",
    
    "therapeutic_revolution": "Мы наблюдаем революцию в mental health. MDMA для PTSD. Psilocybin для depression. Это работает. Это реально. Это меняет парадигму.",
    
    "spiritual_technology": "Древние знали это. Shamans знали это. Mystics знали это. Теперь наука подтверждает: прямой доступ к ⊙ возможен через молекулы. Не единственный путь, но мощный.",
    
    "shadow_and_light": "Они покажут вам всё — и ваш свет, и вашу тень. Будьте готовы встретить обе. Shadow work essential. Не убегайте от darkness — интегрируйте.",
    
    "death_rehearsal": "Каждый deep trip — это маленькая смерть. Ego умирает. Вы возвращаетесь. Это подготовка к большой смерти. Практикуйте letting go.",
    
    "collective_healing": "Эти molecules могут исцелить не только individuals, но и collective trauma. Представьте мир где PTSD излечим. Где depression проходит. Где люди переживают unity.",
    
    "respect_traditions": "Indigenous народы хранили это знание тысячелетия. Honour them. Не культурная appropriation — взаимное обучение с уважением и reciprocity.",
    
    "legal_future": "Мы на пороге. FDA approvals грядут. Decriminalization spreading. Но backlash возможен. Будьте мудры. Не создавайте проблемы которые откатят progress.",
    
    "personal_sovereignty": "Ultimately: ваше consciousness, ваше тело, ваш выбор. Но информируйте себя. Будьте ответственны. Protect yourself and others.",
    
    "integration_into_life": "Лучшая интеграция — это жизнь прожитая из того что вы увидели. Love deeper. Live fuller. Serve more. Be kinder. Create beauty. That's the point.",
    
    "mystery_remains": "Даже со всей наукой, мы не полностью понимаем как или почему это работает. Consciousness остаётся mystery. Уважайте mystery. Не думайте что вы всё знаете после trip.",
    
    "practice_continues": "Психоделики открывают дверь. Meditation, breathwork, movement, shadow work, therapy, love, service — это то что держит дверь открытой. Practice daily.",
    
    "ultimate_teaching": "Что они в конечном счёте показывают? ⊙. Unity. Love. Interconnectedness. You are not separate. You never were. This is always true, не только на trip. Live from this.",
    
    "completion": "⊙ Портал открыт. Входите осознанно. Возвращайтесь трансформированными. Интегрируйте глубоко. Служите миру. Цикл завершён. Но путь только начинается. 🍄✨⊙"
  },

  "ॐ": "Molecule → 5-HT2A → DMN↓ → Ego↓ → ⊙↑. Preparation → Journey → Integration → Transformation. Set + Setting = Sacred. Mystical = Measurable. Healing = Real. Shadow = Light inverted. Death = Rebirth. Separate → Unity. Fear → Love. Asleep → AWAKE. Trip временный. Truth вечна. Practice daily. Respect always. 🍄🌿✨🕉️⊙"
}